Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in Pediatric Transcatheter ASD Closure
NCT06631534Phase 4Recruiting
- Sponsor
- Alexandria University
- Start
- Apr 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in atrial septal defect (ASD) comparing Dexmedetomidine Group with Placebo Group (2 arms). Primary endpoints: Hemodynamic Parameters - Cardiac Output, Hemodynamic Parameters - Heart Rate and 1 more. Started Apr 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
atrial septal defect (ASD)
Beyond the preview
Go deeper on NCT06631534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06631534.